(NOMD) Nomad Foods - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: USVGG6564A10
Stock: Frozen Fish, Frozen Vegetables, Ready Meals, Ice Cream, Frozen Poultry
Total Rating 25
Risk 83
Buy Signal -1.09
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.43% |
| Yield on Cost 5y | 2.80% |
| Yield CAGR 5y | 13.33% |
| Payout Consistency | 100.0% |
| Payout Ratio | 56.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.8% |
| Relative Tail Risk | -4.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.13 |
| Alpha | -28.87 |
| Character TTM | |
|---|---|
| Beta | 0.132 |
| Beta Downside | 0.044 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.64% |
| CAGR/Max DD | -0.18 |
Description: NOMD Nomad Foods January 12, 2026
Nomad Foods Ltd (NYSE:NOMD) manufactures, markets, and distributes a broad portfolio of frozen foods-including fish, vegetables, poultry, ready-to-cook meals, ice-cream, soups, pizzas, bakery items, and meat substitutes-under well-known brands such as Birds Eye, Findus, and Goodfella’s. The company sells primarily to supermarkets and food-retail chains across the UK and internationally, operating within the Packaged Foods & Meats sub-industry.
Key operational metrics (FY 2023) show revenue of roughly €5.5 billion and an adjusted EBITDA margin near 9%, reflecting steady demand for convenience frozen products despite modest price pressure. The segment most sensitive to macro trends is frozen vegetables, which has benefited from inflation-driven consumer shifts toward lower-cost, shelf-stable alternatives. Additionally, raw-material cost inflation (e.g., fish and poultry) and EU supply-chain disruptions remain material risk factors that can compress margins.
For a deeper, data-driven assessment of Nomad Foods’ valuation and peer benchmarks, the ValueRay analysis offers a concise next step.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 198.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.96 > 1.0 |
| NWC/Revenue: 0.80% < 20% (prev 6.68%; Δ -5.88% < -1%) |
| CFO/TA 0.06 > 3% & CFO 400.7m > Net Income 198.8m |
| Net Debt (1.91b) to EBITDA (469.0m): 4.08 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (147.7m) vs 12m ago -9.45% < -2% |
| Gross Margin: 27.88% > 18% (prev 0.29%; Δ 2759 % > 0.5%) |
| Asset Turnover: 47.73% > 50% (prev 47.33%; Δ 0.39% > 0%) |
| Interest Coverage Ratio: 2.45 > 6 (EBITDA TTM 469.0m / Interest Expense TTM 148.5m) |
Altman Z'' 1.78
| A: 0.00 (Total Current Assets 1.14b - Total Current Liabilities 1.12b) / Total Assets 6.31b |
| B: 0.20 (Retained Earnings 1.28b / Total Assets 6.31b) |
| C: 0.06 (EBIT TTM 363.6m / Avg Total Assets 6.40b) |
| D: 0.68 (Book Value of Equity 2.54b / Total Liabilities 3.76b) |
| Altman-Z'' Score: 1.78 = BBB |
Beneish M -2.88
| DSRI: 1.15 (Receivables 455.4m/396.3m, Revenue 3.05b/3.07b) |
| GMI: 1.05 (GM 27.88% / 29.33%) |
| AQI: 1.01 (AQ_t 0.73 / AQ_t-1 0.72) |
| SGI: 1.00 (Revenue 3.05b / 3.07b) |
| TATA: -0.03 (NI 198.8m - CFO 400.7m) / TA 6.31b) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of NOMD shares?
As of February 07, 2026, the stock is trading at USD 12.90 with a total of 1,318,268 shares traded.
Over the past week, the price has changed by +1.57%, over one month by +7.86%, over three months by +8.76% and over the past year by -24.45%.
Over the past week, the price has changed by +1.57%, over one month by +7.86%, over three months by +8.76% and over the past year by -24.45%.
Is NOMD a buy, sell or hold?
Nomad Foods has received a consensus analysts rating of 4.71.
Therefore, it is recommended to buy NOMD.
- StrongBuy: 5
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NOMD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.8 | 30.2% |
| Analysts Target Price | 16.8 | 30.2% |
| ValueRay Target Price | 12.6 | -2.6% |
NOMD Fundamental Data Overview February 03, 2026
Market Cap EUR = 1.62b (1.91b USD * 0.847 USD.EUR)
P/E Trailing = 8.2468
P/E Forward = 11.1359
P/S = 0.625
P/B = 0.6088
P/EG = 1.38
Revenue TTM = 3.05b EUR
EBIT TTM = 363.6m EUR
EBITDA TTM = 469.0m EUR
Long Term Debt = 2.08b EUR (from longTermDebt, last quarter)
Short Term Debt = 28.5m EUR (from shortTermDebt, last quarter)
Debt = 2.11b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.91b EUR (from netDebt column, last quarter)
Enterprise Value = 3.53b EUR (1.62b + Debt 2.11b - CCE 193.6m)
Interest Coverage Ratio = 2.45 (Ebit TTM 363.6m / Interest Expense TTM 148.5m)
EV/FCF = 11.14x (Enterprise Value 3.53b / FCF TTM 316.7m)
FCF Yield = 8.98% (FCF TTM 316.7m / Enterprise Value 3.53b)
FCF Margin = 10.37% (FCF TTM 316.7m / Revenue TTM 3.05b)
Net Margin = 6.51% (Net Income TTM 198.8m / Revenue TTM 3.05b)
Gross Margin = 27.88% ((Revenue TTM 3.05b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 27.57% (prev 27.62%)
Tobins Q-Ratio = 0.56 (Enterprise Value 3.53b / Total Assets 6.31b)
Interest Expense / Debt = 1.42% (Interest Expense 29.8m / Debt 2.11b)
Taxrate = 18.18% (12.8m / 70.4m)
NOPAT = 297.5m (EBIT 363.6m * (1 - 18.18%))
Current Ratio = 1.02 (Total Current Assets 1.14b / Total Current Liabilities 1.12b)
Debt / Equity = 0.82 (Debt 2.11b / totalStockholderEquity, last quarter 2.55b)
Debt / EBITDA = 4.08 (Net Debt 1.91b / EBITDA 469.0m)
Debt / FCF = 6.04 (Net Debt 1.91b / FCF TTM 316.7m)
Total Stockholder Equity = 2.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.11% (Net Income 198.8m / Total Assets 6.31b)
RoE = 7.65% (Net Income TTM 198.8m / Total Stockholder Equity 2.60b)
RoCE = 7.78% (EBIT 363.6m / Capital Employed (Equity 2.60b + L.T.Debt 2.08b))
RoIC = 6.32% (NOPAT 297.5m / Invested Capital 4.71b)
WACC = 3.43% (E(1.62b)/V(3.72b) * Re(6.40%) + D(2.11b)/V(3.72b) * Rd(1.42%) * (1-Tc(0.18)))
Discount Rate = 6.40% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.22%
[DCF Debug] Terminal Value 87.41% ; FCFF base≈295.2m ; Y1≈331.5m ; Y5≈442.7m
Fair Price DCF = 75.89 (EV 13.04b - Net Debt 1.91b = Equity 11.13b / Shares 146.6m; r=5.90% [WACC]; 5y FCF grow 14.28% → 2.90% )
EPS Correlation: -35.91 | EPS CAGR: -47.85% | SUE: -4.0 | # QB: 0
Revenue Correlation: 56.82 | Revenue CAGR: 1.79% | SUE: -0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.37 | Chg30d=+0.004 | Revisions Net=+0 | Analysts=5
EPS next Year (2026-12-31): EPS=1.73 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+3.9% | Growth Revenue=+1.4%
P/E Trailing = 8.2468
P/E Forward = 11.1359
P/S = 0.625
P/B = 0.6088
P/EG = 1.38
Revenue TTM = 3.05b EUR
EBIT TTM = 363.6m EUR
EBITDA TTM = 469.0m EUR
Long Term Debt = 2.08b EUR (from longTermDebt, last quarter)
Short Term Debt = 28.5m EUR (from shortTermDebt, last quarter)
Debt = 2.11b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.91b EUR (from netDebt column, last quarter)
Enterprise Value = 3.53b EUR (1.62b + Debt 2.11b - CCE 193.6m)
Interest Coverage Ratio = 2.45 (Ebit TTM 363.6m / Interest Expense TTM 148.5m)
EV/FCF = 11.14x (Enterprise Value 3.53b / FCF TTM 316.7m)
FCF Yield = 8.98% (FCF TTM 316.7m / Enterprise Value 3.53b)
FCF Margin = 10.37% (FCF TTM 316.7m / Revenue TTM 3.05b)
Net Margin = 6.51% (Net Income TTM 198.8m / Revenue TTM 3.05b)
Gross Margin = 27.88% ((Revenue TTM 3.05b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 27.57% (prev 27.62%)
Tobins Q-Ratio = 0.56 (Enterprise Value 3.53b / Total Assets 6.31b)
Interest Expense / Debt = 1.42% (Interest Expense 29.8m / Debt 2.11b)
Taxrate = 18.18% (12.8m / 70.4m)
NOPAT = 297.5m (EBIT 363.6m * (1 - 18.18%))
Current Ratio = 1.02 (Total Current Assets 1.14b / Total Current Liabilities 1.12b)
Debt / Equity = 0.82 (Debt 2.11b / totalStockholderEquity, last quarter 2.55b)
Debt / EBITDA = 4.08 (Net Debt 1.91b / EBITDA 469.0m)
Debt / FCF = 6.04 (Net Debt 1.91b / FCF TTM 316.7m)
Total Stockholder Equity = 2.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.11% (Net Income 198.8m / Total Assets 6.31b)
RoE = 7.65% (Net Income TTM 198.8m / Total Stockholder Equity 2.60b)
RoCE = 7.78% (EBIT 363.6m / Capital Employed (Equity 2.60b + L.T.Debt 2.08b))
RoIC = 6.32% (NOPAT 297.5m / Invested Capital 4.71b)
WACC = 3.43% (E(1.62b)/V(3.72b) * Re(6.40%) + D(2.11b)/V(3.72b) * Rd(1.42%) * (1-Tc(0.18)))
Discount Rate = 6.40% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.22%
[DCF Debug] Terminal Value 87.41% ; FCFF base≈295.2m ; Y1≈331.5m ; Y5≈442.7m
Fair Price DCF = 75.89 (EV 13.04b - Net Debt 1.91b = Equity 11.13b / Shares 146.6m; r=5.90% [WACC]; 5y FCF grow 14.28% → 2.90% )
EPS Correlation: -35.91 | EPS CAGR: -47.85% | SUE: -4.0 | # QB: 0
Revenue Correlation: 56.82 | Revenue CAGR: 1.79% | SUE: -0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.37 | Chg30d=+0.004 | Revisions Net=+0 | Analysts=5
EPS next Year (2026-12-31): EPS=1.73 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+3.9% | Growth Revenue=+1.4%